Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Northbrook, IL, March 25, 2015 –Astellas (www.astellas.us) has become a national corporate partner of The Trevor Project (www.thetrevorproject.org) to help advance the shared mission of ending...
Read more about Astellas Partners with The Trevor Project to Help Save Young Lives
NORTHBROOK, Ill., March 25, 2015 – Astellas, a leading pharmaceutical company based in Northbrook, Ill., has been named one of America’s Best Employers in the biotechnology industry by Forbes...
Read more about Astellas Named One of America’s Best Employers in 2015 by Forbes Magazine
NORTHBROOK, Ill. and SAN FRANCISCO, March 16, 2015 /PRNewswire/ -- Astellas Pharma US, Inc., a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503) and Medivation, Inc. (Nasdaq: MDVN)...
NORTHBROOK, Ill., March 6, 2015 /PRNewswire/ -- Astellas today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for the use of CRESEMBA®...
Funding will support measles vaccination campaigns in Latin America Washington, D.C. March 5, 2015 – The United Nations Foundation’s Shot@Life Campaign, which helps expand access to...
Follow U.S. news
